News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<H Shrs>HSI Adds 135 Pts at Midday as BYD COMPANY Leaps 4%+; CSPC PHARMA Surges 10%
The HSI ticked up 135 points or 0.55% to near a high of 24,992 at midday. The HSCEI added 79 points or 1% to 8,469. The HSTECH gained 50 points or 1% to 4,811. Total half-day turno...
Reset
Send
The window will close in 5 seconds
<H Shrs>HSI Adds 135 Pts at Midday as BYD COMPANY Leaps 4%+; CSPC PHARMA Surges 10%
Close
Recommend
2
Positive
3
Negative
5
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get TENCENT shares!

The HSI ticked up 135 points or 0.55% to near a high of 24,992 at midday. The HSCEI added 79 points or 1% to 8,469. The HSTECH gained 50 points or 1% to 4,811. Total half-day turnover of the market amounted to $135.775 billion.

Pharma ascended generally. CSPC PHARMA (01093.HK)  +1.110 (+13.603%)    Short selling $142.70M; Ratio 18.296%   's Chairman, Cai Dongchen, increased stake by 49.4 million shares worth $413 million on market yesterday (26th), and its share price rallied 9.6% to close at $8.94 at midday.

Related NewsLoan Prime Rate 1Y for March 2026 in China is 3.00%, unchanged from its last period. The forecast was 3%.
INNOVENT BIO (01801.HK)  +5.700 (+7.179%)    Short selling $278.76M; Ratio 22.259%   reported its first full-year profit, boosting its stock price by 5.7%. SINO BIOPHARM (01177.HK)  +0.070 (+1.203%)    Short selling $98.24M; Ratio 26.179%   's full-year underlying profit rose 31%, but its share price shed 1.7%. HENGRUI PHARMA (01276.HK)  +4.700 (+7.673%)    Short selling $33.22M; Ratio 23.825%   , 3SBIO (01530.HK)  +2.200 (+10.129%)    Short selling $30.92M; Ratio 10.377%   , JUNSHI BIO (01877.HK)  +1.240 (+5.849%)    Short selling $1.19M; Ratio 1.855%   , BEONE MEDICINES (06160.HK)  +9.400 (+5.728%)    Short selling $91.45M; Ratio 25.471%   and INNOCARE (09969.HK)  +0.630 (+5.081%)    Short selling $7.09M; Ratio 6.761%   elevated 5.4-6%, while DUALITYBIO-B (09606.HK)  +27.400 (+10.703%)    Short selling $9.97M; Ratio 5.279%   and SIMCERE PHARMA (02096.HK)  +0.880 (+7.871%)    Short selling $3.57M; Ratio 7.853%   hyped up 8.1% and 7.9%.

Automakers continued to be popular, with BYD COMPANY (01211.HK)  +3.600 (+3.505%)    Short selling $768.92M; Ratio 35.521%   leaping 4.3% to $107.1. Leapmotor A10, its first A-series model, was launched with a starting price of RMB65,800. LEAPMOTOR (09863.HK)  +2.400 (+5.168%)    Short selling $143.03M; Ratio 26.728%   advanced 5.5%, while XIAOMI-W (01810.HK)  +0.620 (+1.911%)    Short selling $518.81M; Ratio 25.634%   and LI AUTO-W (02015.HK)  +1.000 (+1.449%)    Short selling $94.79M; Ratio 26.785%   climbed 1.7% and 2.8%.

Autonomous driving stock PONY-W (02026.HK)  -12.100 (-13.956%)    Short selling $13.26M; Ratio 27.022%   plummeted 13.5% as the company’s 2025 non-GAAP loss widened. Its peer WERIDE-W (00800.HK)  +0.720 (+3.822%)    Short selling $1.00M; Ratio 5.104%   ballooned 4%. Car agency ZHONGSHENG HLDG (00881.HK)  +0.660 (+8.323%)    Short selling $19.46M; Ratio 18.070%   turned to a loss of over RMB1.67 billion last year, yet its share price shot up 8.8%. Lithium stocks TIANQI LITHIUM (09696.HK)  +2.760 (+6.136%)    Short selling $20.10M; Ratio 6.767%   and GANFENGLITHIUM (01772.HK)  +5.800 (+8.529%)    Short selling $100.64M; Ratio 8.230%   mushroomed 4.6% and 7.7%.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-03-27 12:25.)

Related NewsG Sachs Cuts CN 2Q Real GDP Growth Forecast to 4% to Reflect Rising Oil Prices, Slightly Raises Full-Yr Inflation Forecast

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.